Egr-1, the potential target of calcium channel blockers in cardioprotection with ischemia/reperfusion injury in rats

Cellular Physiology and Biochemistry

Volumn 24, Issue 1-2, 2009, Pages 17-24

  Huang, Zhanqin ^a   Li, Haiqing ^a   Guo, Fuxiao ^a   Jia, Qiangyong ^a   Zhang, Yanmei ^a   Liu, Xingping ^a   Shi, Ganggang ^a,b  

^a SHANTOU UNIVERSITY   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Calcium channel blocker; Early growth response gene 1; Hypoxia reoxygenation; Ischemia reperfusion; Myocardium, cardiomyocyte

Indexed keywords

CREATINE KINASE; DILTIAZEM; EARLY GROWTH RESPONSE FACTOR 1; LACTATE DEHYDROGENASE; MALONALDEHYDE; MESSENGER RNA; MYELOPEROXIDASE; NIFEDIPINE; SUPEROXIDE DISMUTASE; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; EGR 1 GENE; ENZYME ACTIVITY; GENE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

RATTUS;

EID: 67650421843     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227809     Document Type: Article

References (32)

1. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, Grinfeld L, Gibbons RJ, Ribeiro EE, DeWood MA, Ribichini F: Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093-2098.
2. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 1987;79:950-961.
3. Bers DM, Barry WH, Despa S: Intracellular Na+ regulation in cardiac myocytes. Cardiovasc Res 2003;57:897-912.
4. 2+ exchange inhibitors in attenuating ischemia-reperfusion injury. Can J Cardiol 2005;21:509-516.
5. Bagchi D, Wetscher GJ, Bagchi M, Hinder PR, Perdikis G, Stohs SJ, Hinder RA, Das DK: Interrelationship between cellular calcium homeostasis and free radical generation in myocardial reperfusion injury. Chem Biol Interac 1997;104:65-85.
6. Wang QD, Pernow J, Sjöquist O, Rydén L: Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc Res 2002; 55: 25-37.
7. Piper HM, Meuter K, Schäfer C: Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 2003;75:S644-648.
8. Huang ZQ, Shi GG, Zheng JH, Liu B: Effects of N-n-butyl haloperidol iodide on rat myocardial ischemia and reperfusion injury and L-type calcium current. Acta Pharmacol Sin 2003;24:757-763.
9. Gao FF, Shi GG, Zheng JH, Liu B: Protective effects of N-n-butyl haloperidol iodide on myocardial ischemia-reperfusion injury in rabbits. Chin J Physiol 2004;47:61-66.
10. Huang ZQ, Shi GG, Gao FF, Liu XP, Christopher TA, Lopez B, Ma XL: Effects of N-n-butyl haloperidol iodide on L-type calcium channel and inreacellular free calcium in rat ventricular myocytes. Biochem Cell Biol 2007;85:182-188.
11. Coleman DL, Bartiss AH, Sukhatme VP, Liu J, Rupprecht HD: Lipopolysaccharide induces Egr-1 mRNA and protein in murine peritoneal macrophages. J Immunol 1992;149:3045-3051.
12. Kaufmann K, Thiel G: Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator. J Cell Biochem 2002;85:381-391.
13. Kaufmann K, Thiel G: Epidermal growth factor and platelet-derived growth factor induce expression of Egr-1, a zinc finger transcription factor, in human malignant glioma cells. J Neurol Sci 2001;189:83-91
14. Yan SF, Fujita T, Lu J, Okada K, Zhou YS, Mackman N, Pinsky DJ, Stern DM: Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000;6:1355-1361.
15. Man K, Ng KT, Lee TK, Lo CM, Sun CK, Li XL, Zhao Y, Ho JW, Fan ST: FTY720 attenuates hepatic ischemiareperfusion injury in normal and cirrhoticlivers. Am J Transplant 2005;5:40-49.
16. Man K, Lee TK, Liang TB, Lo CM, Sun CK, Li XL, Zhao Y, Ho JW, Fan ST: FK409 ameliorates small-for-size liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathway. Ann Surg 2004;240:159-168.
17. Zhang YM, Shi GG, Zheng JH, Tang Z, Gao P, Lv YQ, Guo FX, Jia QY: The protective effects of N-n-butyl haloperidol iodide on myocardial ischemia-reperfusion injury in rats by inhibiting egr-1 overexpression. Cell Physiol Biochem 2007;20:639-648.
18. Zhang YM, Shi GG, Zheng JH, Lv YQ, Gao P, Huang ZQ, Gao FF, Zhou YQ: The protective effect of egr-1 antisense oligodeoxyribonucleotide on myocardial injury induced by ischemia-reperfusion and hypoxiareoxygenation. Cell Physiol Biochem 2008;22:645-652.
19. + -ATPase activity in an immortalized human proximal tubule cell line. J Immunol 2003;170:931-940.
20. 2+ -mediated egr-1 and c-fos expression in murine erythroleukaemia cells by cyclosporin A. Biochem J 1998;335:505-511.
21. Zhang YM, Shi GG, Tang Z, Zheng JH, Li WQ, Guo FX , Jia QY: Effects of N-n-butyl Haloperidol Iodide on Myocardial Ischemia/reperfusion Injury and Egr-1 Expression in Rats. Acta Biochim Biophys Sin (Shanghai) 2006;38:435-441.
22. Jonassen AK, Brar BK, Mjøs OD, Sack MN, Latchman DS, Yellon DM: Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol 2000;32:757-764.
23. Okada M, Fujita T, Sakaguchi T, Olson KE, Collins T, Stern DM, Yan SF, Pinsky DJ: Extinguishing Egr-1-dependent inflammatory and thrombotic cascades after lung transplantation. FASEB J 2001;15:2757-2759.
24. Mak IT, Weglicki WB: Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res 1990;66:1449-1452.
25. Henry PD: Antiperoxidative actions of calcium antagonists and atherogenesis. J Cardiovasc Pharmacol 1991;18:S6-S10.
26. Mason RP, Trumbore MW: Differential membrane interactions of calcium channel blockers: implications for antioxidant activity. Biochemical Pharmacology. 1996;51:653-660.
27. Godfraind T: Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis. Phil. Trans R Soc. B 2005;360:2259-2272.
28. Fujita T, Asai T, Andrassy M, Stern DM, Pinsky DJ, Zou YS, Okada M, Naka Y, Schmidt AM, Yan SF: PKC beta regulates ischemia/reperfusion injury in the lung. J Clin Invest 2004;113:1615-1623.
29. Grimes CA, Jope RS: Cholinergic stimulation of early growth response-1 DNA binding activity requires protein kinase C and mitogen-activated protein kinase kinase activation and is inhibited by sodium valproate in SH-SY5Y cells. J Neurochem 1999;73:1384-1392.
30. Carrasco MA, Riveros N, Ríos J, Müller M, Torres F, Pineda J, Lantadilla S, Jaimovich E: Depolarization-induced slow calcium transients activate early genes in skeletal muscle cells. Am J Physiol Cell Physiol 2003;284:C1438-1447.
31. Lo LW, Cheng JJ, Chiu JJ, Wung BS, Liu YC, Wang DL: Endothelial exposure to hypoxia induces Egr-1 expression involving PKC alpha-mediated Ras/Raf-1/ERK1/2 pathway. J Cell Physiol 2001;188:304-312.
32. Chen CY, Forman LW, Faller DV: Calcium-dependent immediate-early gene induction in lymphocytes is negatively regulated by p21 Ha-ras. J Mol Cell Biol 1996;16:6582-6592.